Trials / Completed
CompletedNCT02355548
Outpatient Treatment of Low-risk Pulmonary Embolism
Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Intermountain Health Care, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking at the safety and effectiveness of treating Patients diagnosed with a low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient hospitalization. Patients have several medical tests done during their Emergency Department visit. Based on those tests, those who are determined to have a low-risk PE are eligible to participate in the study. Those choosing to participate are discharged after 12 hours of medical observation. Patients who choose to participate are followed up by telephone approximately 90 days later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Outpatient Treatment of Pulmonary Embolism | Patients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-02-04
- Last updated
- 2018-11-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02355548. Inclusion in this directory is not an endorsement.